References
- Salvador AH, Beabout JW, Dahlin DC. Mesenchymal chondrosarcoma - observations on 30 new cases. Cancer 1971; 28: 605–15.
- Huvos AG, Rosen G, Dabska M, Marcove RC. Mesenchymal chondrosarcoma - clinicopathologic analysis of 35 patients with emphasis on treatment. Cancer 1983; 51: 1230–7.
- Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC. Mesenchymal chondrosarcoma of bone and soft tissue - a review of 111 cases. Cancer 1986; 57: 2444–53.
- Dabska M, Huvos AG. Mesenchymal chondrosarcoma in the young. A clinicopathological study of 19 patients with explanation of histogenesis. Virchows Arch 1983; 399: 89–104.
- Knott PD, Gannon FH, Thompson LD. Mesenchymal chondrosar-coma of the sinonasal tract: a clinicopathological study of 13 cases with a review of the literature. Laryngoscope 2003; 113: 783–90.
- Gottschalk D, Fehn M, Patt S, Saeger W, Kirchner T, Aigner T. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development. Am J Pathol 2001; 158: 1571–8.
- Aigner T, Loos S, Muller S, et al. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas. Am J Pathol 2000; 156: 1327–35.
- Sandell Li, Morris NP, Robbins JR, Goldring MB. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol 1991; 114: 1307–19.
- Reichenberger E, Aigner T, von der Mark K, Stfiss H, Bertling W. In situ hybridization studies on the expression of type X collagen in fetal human cartilage. Dev Biol 1991; 148: 562–72.
- Unni KK. Dahlin's Bone Tumors. 5th edn. Philadelphia: Lippincott-Raven, 1996.
- Jacobson SA. Polyhistioma. Cancer 1977; 40: 2116–30.
- Bertoni F, Picci P, Bacchini P, et al. Mesenchymal chondrosarcoma of bone and soft tissues. Cancer 1983; 52: 533–41.
- Harwood AR, Krajbich JI, Fornasier VL. Mesenchymal chondro-sarcoma: a report of 17 cases. Clin Orthop 1981; 158: 144–8.
- Dahlin DC, Henderson ED. Mesenchymal chondrosarcoma. Cancer 1962; 15: 410–7.
- Oganesian A, Zhu Y, Sandell Li. Type IIA procollagen amino propeptide is localized in human embryonic tissues. J Histochem Cytochem 1997; 45: 1469–80.
- Girkontaité I, Frischholz S, Lammi P, et al. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 1996; 15: 231–8.
- Pileri SA, Roncador G, Ceccarelli C, et al. Antigen retrieval techniques in immunohistochemistry: comparison of different meth-ods. J Pathol 1997; 183: 116–23.
- Scully SP, Layfield Li, Harrelson JM. Prognostic markers in chondrosarcoma: evaluation of cell proliferation and or regulators of the cell cycle. Sarcoma 1997; 1: 79–87.
- Daugaard S, Myllylä R, Schiodt T, et al. Clinical and histopatho-logical prognostic factors in chondrosarcomas. Sarcoma 1997; 1: 47–54.
- Rushing EJ, Armonda RA, Ansari Q, Mena H. Mesenchymal chondrosarcoma. A clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system. Cancer 1996; 77: 1884–91.
- Scheithauer BW, Rubinstein Li. Meningeal mesenchymal chondro-sarcoma. Cancer 1978; 42: 2744–52.